APA (7th ed.) Citation

Wallentin, L., & Katus, H. (2014). Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio, J. J., Tomek, A., Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: Serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013. International journal of cardiology, 170(3), .

Chicago Style (17th ed.) Citation

Wallentin, Lars, and Hugo Katus. "Review of the Accumulated PLATO Documentation Supports Reliable and Consistent Superiority of Ticagrelor over Clopidogrel in Patients with Acute Coronary Syndrome: Commentary on: DiNicolantonio, J. J., Tomek, A., Inactivations, Deletions, Non-adjudications, and Downgrades of Clinical Endpoints on Ticagrelor: Serious Concerns over the Reliability of the PLATO Trial, International Journal of Cardiology, 2013." International Journal of Cardiology 170, no. 3 (2014).

MLA (9th ed.) Citation

Wallentin, Lars, and Hugo Katus. "Review of the Accumulated PLATO Documentation Supports Reliable and Consistent Superiority of Ticagrelor over Clopidogrel in Patients with Acute Coronary Syndrome: Commentary on: DiNicolantonio, J. J., Tomek, A., Inactivations, Deletions, Non-adjudications, and Downgrades of Clinical Endpoints on Ticagrelor: Serious Concerns over the Reliability of the PLATO Trial, International Journal of Cardiology, 2013." International Journal of Cardiology, vol. 170, no. 3, 2014.